Latest Organofluorides Stories
Expanded capacity to produce new low-global-warming materials driving reductions, with support from proposed regulations; announcement made at White House event MORRIS TOWNSHIP, N.J.,
The Firm is representing numerous Risperdal lawsuit plaintiffs who allegedly developed gynecomastia, or male breast growth, due to their use of the antipsychotic drug. New
DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the U.S.
The Firm is representing a number of clients in Risperdal lawsuits that allege use of the antipsychotic medication caused gynecomastia, or male breast growth. New
50% of Patients Treated with Mipsagargin had No Tumor Growth at Four Months SAN ANTONIO, Sept. 8, 2014 /PRNewswire/ -- GenSpera, Inc.
MarketOptimizer.org adds new report "Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023" to its store.
DALLAS, September 7, 2014 /PRNewswire/ -- MarketOptimizer.org adds "Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023", a new research report to its
Eleven-month Increase in Median OS Reported with VT-122 plus Sorafenib, Compared to Sorafenib Alone.
Pharmacokinetics, Safety and Tolerability of NVR-1221 Support Advancement to Phase 1b Clinical Studies in Patients with Chronic HBV Infection DOYLESTOWN, Pa., Sept.
- a meat pie that is usually eaten at Christmas in Quebec